Gulf Resources (GURE) Very Strong Growth; Upward View On NeuroDerm (NDRM)


Shares of Gulf Resources, Inc. (Nasdaq:GURE) soared more than 12% in after-hours trading Tuesday as the company delivered strong growth in its quarterly financial results, primarily driven by its subsidiary Shouguang City Rongyuan Chemical Co., Ltd.

For the third quarter 2015, Gulf Resources posted net revenue of $42.6 million, a 37% increase year over year, and net income of $10.68 million, or $0.23 per diluted share, compared to net income of $5.04 million, or $0.13 in the same oerdiod the prior year

GURE stock finished the regular session at $1.88 with a total volume of 70,598 shares traded during the day

Gulf Resources, which manufactures and trades in bromine, crude salt, and specialty chemical products in the People’s Republic of China, has 46.28M Shares Outstanding, Market Capitalization (intraday) of $87.00M and GURE stock 52-week range is $1.00 – $2.95



NeuroDerm Ltd. (Nasdaq:NDRM) closed at $18.86, down $0.65 (or -3.33%), and 155,613 of its shares exchanged hands on Tuesday’s trading session

Investment analysts at Raymond James initiated coverage on the company’s stock with an Outperform rating and a price target of $28.00

NeuroDerm will release its quarterly earnings report in a few hours before the market opens

NeuroDerm, a clinical-stage pharmaceutical company developing next-generation treatments for central nervous system (CNS) disorders, has 21.54M Shares Outstanding, Market Capitalization (intraday) of $406.19M and NDRM stock 52-week range is between $5.67 and $26.50 per share


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at